ba0003pp153 | Cell biology: osteoclasts and bone resorption | ECTS2014
Vermeer Jenny A.F.
, Renders Greetje A.P.
, van Duin Marion A.
, Jansen Ineke D.C.
, Bakker Lieneke F.
, Kroon Sophie A.
, de Vries Teun J.
, Everts Vincent
Bisphosphonates (BPs) are used to treat bone diseases characterized by excessive bone resorption. However, BPs can negatively affect the jaw bone by causing osteonecrosis of the jaw. Previously, we showed that BPs differently affect long-bone and jaw osteoclast precursors. Administration of BPs in vivo reduced the number of jaw bone marrow cells, without affecting long-bone marrow cells. Yet, BPs increased bone volume and mineral density of both long bone and jaw. Her...